SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001819790-21-000020
Filing Date
2021-05-11
Accepted
2021-05-11 16:28:19
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tars-20210331.htm   iXBRL 10-Q 883774
2 EX-10.1 exhibit101lian-tarsusxdeve.htm EX-10.1 397784
3 EX-31.1 exhibit3111.htm EX-31.1 11872
4 EX-31.2 exhibit3121.htm EX-31.2 12128
5 EX-32.1 exhibit3211.htm EX-32.1 9960
6 EX-32.2 exhibit3221.htm EX-32.2 9902
  Complete submission text file 0001819790-21-000020.txt   4863549

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tars-20210331.xsd EX-101.SCH 29419
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tars-20210331_cal.xml EX-101.CAL 69198
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tars-20210331_def.xml EX-101.DEF 134951
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tars-20210331_lab.xml EX-101.LAB 407852
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tars-20210331_pre.xml EX-101.PRE 257748
12 EXTRACTED XBRL INSTANCE DOCUMENT tars-20210331_htm.xml XML 641326
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39614 | Film No.: 21911693
SIC: 2836 Biological Products, (No Diagnostic Substances)